Ratio Of Good To Bad Bacteria In Stool Samples Of Children As Young As Four Months Could Predict Those Who Will Develop Type 1 Diabetes
Dr. Mark Atkinson, Ph. D., American Diabetes Association Eminent Scholar
The University of Florida
Letter from the Editor: EASD Report
The EASD (European Association for the Study of Diabetes) just finished their 46th Annual Meeting and there was a lot of great information. This issue will condense and review for you the most exciting and new information that was presented at...
Test Your Knowledge #541: A 55-year-old woman who has had Type 2 diabetes for 15 years is evaluated...
A 55-year-old woman who has had Type 2 diabetes for 15 years is evaluated to review her blood glucose levels and adjust her medication.
New Product: Sanofi-Aventis launches iBGStar iPhone diabetes device
iBGStar iPhone diabetes device
Sanofi-Aventis launched its
Tool for Your Practice: Understanding Insulin Therapy
Understanding Insulin Therapy
This week's Nipro...
EASD: Novel DPP-4 Drug Works in Renal Impairment
EASD: Novel DPP-4 Drug Works in Renal Impairment: The novel diabetes drug linagliptin (proposed trade name Ondero) may find a niche in treating patients with kidney problems. In a phase III study of patients who couldn't take metformin because of...
EASD: Lixisenatide Shows Potential
EASD: Lixisenatide Shows Potential: Lixisenatide monotherapy significantly improves glycemic control with a pronounced postprandial effect in patients with Type 2 diabetes, and is safe and well tolerated, according to a phase 3 trial. Lixisenatide...
EASD: Adding Incretin to Insulin Lowers HbA1c
Adding exenatide to insulin glargine for patients who aren't fully controlled with insulin glargine and/or other oral agents can help to improve their blood glucose....
EASD: Preliminary Study Shows: Early Routine Diabetes Treatment Works as Well as Early Intensive Therapy
Early treatment of screen-detected Type 2 diabetes works regardless of how intensively glucose, lipids, and blood pressure are managed, experts concluded on the basis of a large randomized trial presented....
EASD: Continuous Monitors May Miss Hypoglycemia
Continuous blood glucose monitors may not accurately detect low blood sugar, researchers found....
EASD: Frequent Hypoglycemia Key in Cardiac Risk
Patients with Type 1 diabetes who have repeated episodes of hypoglycemia appear to be at risk for early signs of atherosclerosis, researchers said....
EASD: Pioglitazone-Sitagliptin Combination Achieves Durable Glycemic Control
Adding 50 mg of sitagliptin (Januvia) to pioglitazone (Actos) allowed patients with Type 2 diabetes to achieve sustained glycemic control, a yearlong trial showed....
EASD: New Drug Classes Entering Type 2 Pipeline
Farnesoid X receptor agonists, 11-β-HSD1 inhibitors, and glucokinase activators are some of the new approaches to treating Type 2 diabetes described in research presented, but some senior researchers expressed doubts about the...
EASD: Once-Weekly Exenatide Benefit Sustained over 52 Weeks
Once-Weekly Exenatide maintains a drop in A1c of 2 points for more than 52 weeks....
EASD: Legacy of Early Intensive Glucose Control Lasts a Decade
Intensive glucose control even after 10 years still shows clinical benefits and even rises over time....
EASD: Moderate Wine Drinking Lowers Fasting Glucose in Type 2 Diabetes
A glass of merlot or perhaps sauvignon blanc with dinner may offer modest benefits for patients with Type 2 diabetes, said researchers....
EASD: Type 2 Diabetes Less Prevalent in Women but Just as Deadly
Men are up to two and a half times more likely to have newly diagnosed Type 2 diabetes than women, but once a woman is diagnosed, the disease is just as deadly for them as for men....
EASD: Weight Loss with SGLT2 Inhibitors but More Infections
Three possible first in class drugs in the sodium glucose co-transporter (SGLT2 inhibitor) class showed improvements in glycemic control and weight loss, but infections proved troublesome, researchers...
EASD: Fracture Risk Demands Attention in Diabetes Patients
Because Type 2 diabetes weakens the bone in often undetectable ways, both directly and indirectly via treatment side effects, experts urged increased awareness....
